Sorin Group S.p.A. Celebrates Delivery Of 10,000Th Heart- Lung Machine

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

MILAN--(BUSINESS WIRE)--Sorin Group (MIL:SRN) (Reuters Code: SORIN.MI), a global medical company and a leader in the treatment of cardiovascular diseases, is proud to announce the delivery of its 10,000th heart-lung machine to Brigham and Women’s Hospital*, Boston, MA, USA.

The heart-lung machine helps sustain a patient undergoing open-heart surgery procedures, providing blood oxygenation and circulation (extracorporeal support) to the brain and major organs while the patient's heart and lungs are temporarily bypassed. Every year, more than 1.5 million patients worldwide suffer from cardiac disease requiring extracorporeal support from a heart-lung machine.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC